and chemistry, leading Walker to study at Durham University (►Fig. 3a, b), some 25 miles to the north. John Walker (►Fig. 4) ended a protracted period of academic and itinerant study at the age of 31 years, and in 1812, he returned to his hometown, soon to open his own shop as a "chemist and druggist" at 59 High Street (►Fig. 5). Twelve years later (1824), positioned at the hearth of his fireplace, Walker experimented with various chemical compounds that he thought might break into flames when dried and scraped on a rough surface, yet do so without explosion.
The chemical paste most safely combustible was sulfur based, and Walker was able with little refinement to begin selling "ignitable wooden sticks" from display cases in his shop on High Street. The matches were offered in small tins containing 50 matches (►Fig. 6a).
John Walker laid no formal claims to novelty and, thus unarmed with patent protection, copycats quickly arose in At the time of John Walker's mid-19th-century death (1859) and burial in the Parish Yard of the Church of St. Mary the Virgin, in nearby Norton, yellow (the so-called "white") phosphorus was added to the sulfur-based matchstick coating to trigger more volatile flame. Encouraged by ease of use and increased demand, the new matches became highly sought commodities, and manufacturing changed from small entrepreneurial shops to large factories in London, Glasgow, Amsterdam, Paris, Vienna, and Berlin.
The phosphorus-based vats released toxic fumes into the factory air (particularly in the dipping centers and drying rooms), and "dippers and handlers" exposed to the fumes and the fat-soluble matchstick paste within 3 to 5 years suffered gingivitis, sequestration of alveolar crest bone, and osteonecrosis of mandibular and maxillary bone stock ("phossy jaws"). Oral and orocutaneous fistulae were common in the afflicted (►Fig. 7). 5 In the more unduly exposed, the tracheopulmonary tree became a second end point of toxicity, and cough, sputum production, and hemoptysis were common ("phossy lung"). Systemic toxicity developed in the more chronically afflicted, provoking seizures ("phossy brain") and causing leukopenia and anemia ("phossy marrow"). (►Fig. 8) Factory owners, seeking to control the environmental risks, required serial oral examination of those at greatest risk (►Fig. 9a, b). 6 The incidence of "phossy jaw" and other toxic responses abated rather rapidly after yellow ("white") phosphorous in matchstick paste was proscribed by the International Berne (Switzerland) Convention of 1906. 1
"Bis-Phossy Jaw" (Bisphosphonate-Induced Osteonecrosis): A Modern Equivalent
Like the friction match, bisphosphonates were developed in the innovative 19th century. The chemicals, with two phosphonate (PO 3 ) groups, were first employed to soften water used, at the time, to hydrate orange groves. Their chemical attributes were investigated in the 1960s, but it was 30 years before their mechanism of effect on bone was delineated by Merck & Company investigators. Merck launched alendronate (Fosamax; Merck, Kenilworth, NJ) in the 1990s to treat conditions that feature bone fragility 12 ; other pharmaceutical companies followed suit. Osteoporosis, bone metastasis (breast and prostate), multiple myeloma, and Paget primary disease of bone (osteitis deformans) are but a few of the human disorders profoundly improved when bisphosphonates are used, either as a preventive or as treatment. 28 The mechanism of action of bisphosphonates remains uncertain. Bench research to date, however, suggests bisphosphonates throttle the osteoclast (warranting dysfunction without triggering cell death) and (in ways not yet certain) disallow inherent angiogenic repair (►Fig. 10). Migliorati et al and Lam et al, it follows, speculate side effects of bisphosphonates that lead to osteonecrosis are the result of a combination of (1) inhibition of bone remodeling and (2) decreased endosteal blood flow. 19, 28 The clinical effects of bisphosphonates, like the experience in factory workers exposed to white phosphorous, persist for prolonged periods of time (decades), even in cases in which treatment has been discontinued. 25, 26 The longevity of mal effects has led to comparative studies of the binding of various bisphosphonates to bone. Potency, duration of oral and intravenous administration (particularly 3-5 years), local oral anatomy and disease, and age are just some of the variables that appear to affect clinical outcomes, whether after infusion or oral consumption.
Case Report
A 68-year-old nondiabetic female with osteoporosis (on 10 mg alendronate/Fosamax daily for 2 years) and a history of breast cancer presented to her local dentist, complaining of unrelenting pain in the left lower jaw. Believing the pain was odontogenic in nature, mandibular teeth numbers 20, 21, 22, Pain in the body of the mandible persisted despite the extractions, and socket number 20 failed to heal after oral rinses, serial curettage, and multiple courses of clindamycin. In short order, the patient was referred to the Otolaryngology-Head & Neck Service at Regional Medical Center Bayonet Point. Upon presentation, a 1.0 Â 2.5 cm area of exposed bone was noted in the region of the body of the left mandible, accompanied by intense pain, fever, granulation tissue, pustular drainage, and malodor. Cultures revealed normal mouth flora.
Sequestrectomy and histologic study of specimens failed to reveal breast cancer metastatic to the body of the mandible. Computed tomography (CT) confirmed extensive bone necrosis and a suspected pathologic fracture of the left body of the mandible. Tracheostomy, resection of necrotic left mandibular body to the point of active bleeding, copious irrigation, and placement of an external fixator (Joe Hall Morris appliance 39 ) followed, as did a percutaneous endoscopic gastrostomy (PEG) for nutrition. Oral consumption of alendronate was stopped.
Some 90 days later, the compromised oral soft tissue appeared to have sufficiently healed. The prior surgical site was approached from below, by way of a large cervical apron flap, sweeping downward from each mastoid tip to the sternoclavicular notch. A left DePuy Synthes (Depuy Synthes, West Chester, PA)-Materialise (Materialise, Glen Burie, MD) patient-specific titanium implant (based on mirrored images of the right mandible) was secured to bone stock, distal, and mesial to the resection. Temporary fixation of a patientspecific mandibular positioning guide, custom screw-hole guides (for precise drill-hole location), and trocar guide cylinders (with irrigation ports) facilitated the accuracy of Fig. 8 End points of yellow ("white") phosphorous toxicity, leading to "phossy jaw," "phossy lung," "phossy marrow," and "phossy brain." the reconstruction. Four screws secured the implant to the left ramus and five to the right symphysis and parasymphysis; bicortical screw length varied, as predetermined by computer analysis (►Figs. 11a, b and 12a, b) . The past 18 months have been free of sequelae. The remaining bone stock fails to reveal areas of necrosis, and avoidance of alendronate continues. The PEG tube has been removed. Fabrication of a complete lower denture would be considered in ensuing months.
Discussion
Hellstein and Marek in 2005 rhetorically ask if bisphosphonate-induced osteonecrosis is "the phossy jaw of the 21st century." We believe it is and find the long-forgotten parallels uncanny. Further, we are disinclined to use the words "bisphosphonate-associated" and more inclined to acknowl-edge a stronger linkage by instead using "bisphosphonateinduced." We concur with Jiminez-Soriano and Bagan, Hellstein and Marek, and Abu-id et al: "bis-phossy" is a catchy, insightfully descriptive term that implies the consequential relationship. 22, 23, 33 The mandible, mandibular vestibule, and anterior floor of the mouth enjoy a rich blood supply by way of terminal branches of the external carotid artery. Of particular note, distribution is by endosteal and by outer and inner periosteal systems, the latter distinguished by a three-tiered vasculature, above and below the mylohyoideus musculature 40 (►Fig. 13a). The terminal arborization is not a new revelation: it was noted by Cryer in 1916 41 and dramatized by the studies of Knapp et al and Dempster and Enlow when they injected the inferior alveolar arteries with India ink, after extraction of organic material with ethylendiamine 42-45 (►Fig. 13b). The biomechanism by which mandibular bone and its microvasculature is singled out as an end point of toxicity requires much further study, although the suspected sequence and pathogenesis of bis-phossy jaw can be depicted, as it is in ►Fig. 10. Future clinical and bench studies might include angiography of the endosteal vasculature during and after bisphosphonate administration; serial biennial conebeam CT monitoring of the mandible in patients consuming bisphosphonate; and the viability of bone grafts despite patients having discontinued bisphosphonates.
Clinical research would do well to explain the proclivity of the jaws and the adjacent soft tissue to osteonecrosis compared with skull and long bones. 20, 22, 28, 30 Savvy dental practitioners continue to be aware of unrelenting pain as a marker of compromised bone and cognizant of tardy healing of gingiva in patients consuming bisphosphonates. They would astutely offer preventive care early and weigh extraction and surgical intervention according to perceived risk. 6, 13, 16, 21, 31, [35] [36] [37] Temporary use of an external fixator in this case begged time for healing of the soft-tissue envelope. Deferment of definitive repair also allowed design of a patientspecific device and outcomes model. The timing and successful mechanics of surgical intervention in this case may or may not be directly applicable, however, to other patients. Fig. 10 Pathophysiology and end points of bisphosphonate-induced toxicity, leading to "bis-phossy jaw." Fig. 11 (a and b) Extirpation and stabilization with an external fixator, awaiting soft-tissue healing. Fig. 12 (a and b) Computer model of resection, positioning guide, and end result after placement of patient-specific implant.
We are particularly aware of the unrelenting, decades-long proclivity of bisphosphonates to bind to bone, as are the patient and her referring doctors. As such the residual bone and soft tissue of the ipsilateral and the contralateral mandible and perhaps even the anterior floor of the mouth may become compromised. Should evidence of necrosis recur, secondary, even tertiary, procedures may unfortuitously follow. 
